Ensem Therapeutics

Biotechnology ResearchUnited States11-50 Employees

The name ENSEM connotes innovations in integrating groundbreaking technologies to decipher structural ENSEMbles and kinetics for drug design. 

ENSEM is a pioneering drug discovery and development company that leverages its unique Kinetic Ensemble™ platform to develop innovative small molecule precision medicines for oncology, with potential expansion into genetic disorders and other disease areas.  

ENSEM integrates computational and AI deep learning methodologies with advanced experimental techniques to identify non-obvious binding pockets and accelerate structure-based drug design, with a focus on high-value and difficult-to-drug targets.

Sign up for free to view info

Email Format Employee directory